ETFs most similar to THNR
The funds whose holdings overlap Amplify Weight Loss Drug & Treatment ETF the most, by weight. as of Jun 30, 2026SEC filing
By holdings overlap
| Fund | Category | Overlap with THNR | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| THNRAmplify Weight Loss Drug & Treatment ETF | Global | — | 0.59% | $5.6M | −0.4% | 1.69% | |
| OZEMRoundhill GLP-1 & Weight Loss ETF | Biotech & Health Innovation | 61% | 0.59% | $55M | +1.4% | 1.39% | side by side |
| MEDXHorizon Kinetics Medical ETF | Health Care | 32% | 0.85% | $17M | +11.6% | 1.16% | side by side |
| HRTSTema ETF Trust Tema Heart & Health ETF | Health Care | 28% | 0.75% | $54M | +11.2% | 1.31% | side by side |
| PPHVanEck Pharmaceutical ETF | Health Care | 28% | 0.36% | $1.0B | +18.3% | 1.94% | side by side |
| PJPInvesco Pharmaceuticals ETF | Health Care | 27% | 0.57% | $555M | +29.5% | 0.92% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.